A 12 Months Prospective Study Comparing Functional Outcome Scores in Hip Arthroscopic Labral Repair Versus Debridement
Launched by AIN SHAMS UNIVERSITY · Feb 24, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical methods to treat hip injuries, specifically focusing on labral tears, which are injuries to the cartilage in the hip joint. The researchers want to compare the outcomes of two procedures: one that repairs the labrum (the cartilage) and another that cleans up damaged tissue (called debridement). The goal is to find out which method helps patients feel better and regain function in their hips after surgery.
To participate in this study, you need to be between 18 and 60 years old and have a specific type of hip problem called femoroacetabular impingement, which can cause pain and limit movement. However, if you have had previous hip surgery or have certain other hip conditions, you may not be eligible. If you join the study, you can expect to be followed for 12 months to see how well you recover and how your hip function improves after one of these procedures. This trial is currently looking for participants, so it could be a good opportunity for those dealing with these hip issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Sex: both sexes.
- • Age: 18 years - 60 years.
- • Femoroacetabular impingement (FAI) including all types (cam, pincer, and combined).
- • Traumatic Labral tears
- Exclusion Criteria:
- • Previous hip surgery.
- • Hip joint dysplasia, defined by both center edge (CE) angles \<25 degrees and Acetabular Index angle \>10 degrees.
- • Osteoarthritis grade \>2 according to Tönnis classification.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Karim A Salem, MD
Principal Investigator
Ain Shams University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported